Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD — Stella

Recruiting

Back to Chronic Obstructive Pulmonary Disease trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

Clinical Physiology Laboratory, Edmonton, Alberta

Key details

Phase

Safety & dosing

Sponsor

University of Alberta

Collaborators

Canadian Institutes of Health Research (CIHR)

Enrollment target

~160 participants

Started

March 2022

Primary completion

May 2027

Age range

40 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov